HOME >> BIOLOGY >> NEWS
Rutgers wins NIH grants to study how tea consumption, diet are tied to cancer

NEW BRUNSWICK/PISCATAWAY, N.J. - Cancer researcher Chung S. Yang and collaborators at Rutgers University will study tea and its potential to prevent cancer under a $5.7 million, 5-year program project grant from the National Cancer Institute of the National Institutes of Health (NIH). Another group led by Yang received a planning grant to organize a collaborative program to study diet and cancer.

Going beyond studies that show tea inhibits cancer formation in laboratory animal models, the program project, called "Inhibition of Carcinogenesis by Tea and Tea Constituents," will systematically investigate how tea constituents might block the biological processes that lead to cancer formation and whether such blocking action could prevent cancer in humans.

Although tea has been extolled as a cancer preventive agent, Yang is careful to point out that tea-drinking by humans has not been clearly demonstrated to affect formation of cancer. "The objective of the program project is to gain a comprehensive understanding of tea and cancer prevention by combining the results of studies involving animals, cell lines, and humans," Yang said. The investigators will also research many other biological effects of tea, a beverage second only to water in human consumption.

The program project will support the collaborative research of Professors Yang (the principal investigator), Allan H. Conney, Hou-Tuan Huang, Harold Newmark, Kenneth Reuhl, and Joseph Rice, all of the Ernest Mario School of Pharmacy at Rutgers. The program will also include Professor Chi-Tang Ho of Cook College at Rutgers, as well as Dr. Zigang Dong of the University of Minnesota, as key members. The group of investigators has received extensive prior recognition for work demonstrating the cancer preventive and other biological activities of tea.

Yang and collaborators also received a $170,000 planning grant from the National Cancer Institute to organize a multidisciplinary
'"/>

Contact: Bill Haduch
bhaduch@ur.rutgers.edu
732-932-7084
Rutgers, the State University of New Jersey
17-Jan-2002


Page: 1 2

Related biology news :

1. Rutgers-Newark biologist links presence of protein to spread of cancerous cells
2. Rutgers-Newark scientist: Mosquitoes may carry lethal parasite
3. Rutgers cancer prevention expert calls for FDA action to reduce colon cancer and osteoporosis
4. Rutgers chemist uses NMR to elucidate protein-DNA interaction
5. Ocean dye to help Rutgers scientists trace Hudson Rivers path miles into the Atlantic
6. Rutgers ecologists and Brooklyn Botanic Garden botanists to plan Beijing Olympics Forest Park
7. Radioactive and toxic waste site plans are a recipe for disaster, says Rutgers sociologist
8. Rutgers researcher offers a new perspective on human evolution
9. Rutgers scientists discover protein in brain affects learning and memory
10. President Bush names Rutgers Evelyn Witkin for nations highest science honor
11. Rutgers geneticist to battle autism with $3.7 million NIH grant

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/12/2020)... ... August 12, 2020 , ... Mosio ... are ideal for public health agencies of all sizes. With a focus on ... at-risk individuals find appropriate health care, Mosio helps public health departments automate communications ...
(Date:8/5/2020)... PENSACOLA, Fla. (PRWEB) , ... August 05, 2020 , ... ... to cover two new innovations, CoreText™ and ProText™, making them the first Wharton’s jelly ... a defect using a syringe. The company’s solutions are the first Wharton’s jelly allograft ...
(Date:7/31/2020)... FRANCISCO (PRWEB) , ... July 30, 2020 , ... ... maturing prescription digital therapeutics product portfolio with a near term focus on Type ... biotech and pharma commercialization experience across multiple therapeutic areas and classes. As Chief ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 17, 2020 , ... ... firm for the life sciences and food industries, is pleased to announce that ... Clinical Research – Business Development. , Charles is an accomplished and results-driven sales ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Technology (MIT) has expanded the company’s exclusive license to include clinical applications ... point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast ...
(Date:7/10/2020)... , ... July 09, 2020 , ... ... cell therapy, today announced the hiring of Allen R. Nissenson, M.D., F.A.C.P., as ... oversee the clinical development of Sentien’s lead product, SBI-101. Dr. Nissenson serves ...
(Date:7/7/2020)... , ... July 06, 2020 , ... ... Awards. Entries from Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts ... Bio-IT World has hosted an elite awards program, highlighting outstanding examples of how ...
Breaking Biology Technology:
Cached News: